People are also afraid of tests that involve MRI scans and biopsies. These are the reasons why we are working on developing a test procedure that estimates the risk of prostate cancer precisely ...

A global research team has discovered a breakthrough set of urine biomarkers for prostate cancer that outperform the ...

Traditional methods like MRI are largely ... future of prostate cancer care. Using deep learning, Avenda Health software maps a patient's cancer in 3D, giving physicians precise information ...

The study identified a set of biomarkers in urine that were able to indicate the presence and severity of prostate cancer with a high degree of precision ... Large-scale clinical trials are ...

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.